MCM
M28 Capital Management Portfolio holdings
AUM
$58.6M
This Quarter Return
+2.88%
1 Year Return
+32.71%
3 Year Return
+247.5%
5 Year Return
–
10 Year Return
–
AUM
$75.7M
AUM Growth
+$75.7M
(-14%)
Cap. Flow
-$14M
Cap. Flow
% of AUM
-18.56%
Top 10 Holdings %
Top 10 Hldgs %
97.31%
Holding
14
New
–
Increased
3
Reduced
4
Closed
2
Top Buys
| 1 |
Curis
CRIS
|
$1.26M |
| 2 |
SLN
Silence Therapeutics
SLN
|
$1.2M |
| 3 |
Wave Life Sciences
WVE
|
$364K |
Top Sells
| 1 |
TG Therapeutics
TGTX
|
$4.89M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$4.51M |
| 3 |
BridgeBio Pharma
BBIO
|
$2.38M |
| 4 |
Stoke Therapeutics
STOK
|
$1.98M |
| 5 |
Rocket Pharmaceuticals
RCKT
|
$1.82M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Wave Life Sciences
WVE
$1.53B
| $25.7M | 33.91% | 7,050,000 +100,000 | +1% | +$364K |
|
|
2
Rocket Pharmaceuticals
RCKT
$354M
| $12.5M | 16.55% | 630,380 -91,700 | -13% | -$1.82M |
|
3
Invivyd
IVVD
$204M
| $9.71M | 12.83% | 9,248,250 | – | – |
|
|
SWTX
4
DELISTED
SpringWorks Therapeutics
SWTX
| $5.18M | 6.85% | 197,700 | – | – |
|
|
5
Curis
CRIS
$20.9M
| $4.98M | 6.58% | 6,000,000 +1,517,858 | +34% | +$1.26M |
|
|
6
Stoke Therapeutics
STOK
$1.08B
| $3.68M | 4.86% | 346,190 -186,700 | -35% | -$1.98M |
|
|
7
TG Therapeutics
TGTX
$4.65B
| $3.54M | 4.68% | 142,500 -197,000 | -58% | -$4.89M |
|
8
ProQR Therapeutics
PRQR
$237M
| $3.1M | 4.09% | 1,910,600 | – | – |
|
|
9
BridgeBio Pharma
BBIO
$9.89B
| $2.86M | 3.78% | 166,200 -138,500 | -45% | -$2.38M |
|
10
Arrowhead Research
ARWR
$3.05B
| $2.4M | 3.18% | 67,400 | – | – |
|
|
SLN
11
Silence Therapeutics
SLN
$227M
| $2M | 2.64% | 363,800 +217,900 | +149% | +$1.2M |
|
|
NEXI
12
DELISTED
NexImmune, Inc. Common Stock
NEXI
| $37.6K | 0.05% | 133,442 | – | – |
|
13
Atara Biotherapeutics
ATRA
$84.6M
| – | – | -439,300 | Closed | -$1.27M |
|
|
14
Ionis Pharmaceuticals
IONS
$6.79B
| – | – | -126,300 | Closed | -$4.51M |
|